Home > Income Statement > CIPLA

CIPLA
Revenue

    Back to Income Statement
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹27,548 Cr₹25,774 Cr₹22,753 Cr₹21,763 Cr₹19,160 Cr

What is the latest Revenue of CIPLA ?

The latest Revenue ratio of CIPLA is ₹27,548 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹27,548 Cr
Mar2025₹25,774 Cr
Mar2024₹22,753 Cr
Mar2023₹21,763 Cr
Mar2022₹19,160 Cr

How is Revenue of CIPLA Trending?

Years Revenue % Change
Mar2026 ₹27,548 Cr
6.88
Mar2025 ₹25,774 Cr
13.28
Mar2024 ₹22,753 Cr
4.55
Mar2023 ₹21,763 Cr
13.59
Mar2022 ₹19,160 Cr -

Compare Revenue of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹109,874.4 Cr 2.3% -2.7% -18.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,803.0 Cr 0.2% -5.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹253,833.0 Cr 4.9% -0.5% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,461.0 Cr -1.1% -8.5% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,463.0 Cr 7.8% 11% 1.2% Stock Analytics
MANKIND PHARMA ₹102,584.0 Cr 9.1% 0.3% 2.2% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

2.3%

-2.7%

-18.9%

SENSEX

-0.6%

-0.5%

-13.2%


You may also like the below Video Courses